One of 135 verified index entries.
28–31OCT 2026
Industry-adjacentConferenceIn-person

HEMO 2026 — Brazilian Congress of Hematology, Hemotherapy & Cell Therapy

Brazil's national hematology, hemotherapy and cell-therapy congress; hemotherapy (blood banking and transfusion) and cryopreserved cell therapy are temperature-controlled, but they are two of around ten clinical tracks within a broad hematology congress rather than a cold-chain event.

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH) · Riocentro
Rio de Janeiro, BR
Industry-adjacent
Doors open in
99days
Visit event website Sync all events in this categoryVerified 20 Jul 2026

Overlaps withTIACA Air Cargo Forum 2026, Global Health Exhibition 2026

The ColdChainer Briefing

What it is

HEMO is the annual congress of the Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), Brazil's hematology and hemotherapy society, held at Riocentro in Rio de Janeiro. Its programme runs multiple simultaneous tracks across clinical hematology, oncohematology, hemotherapy (blood banking and transfusion) and cell therapy.

Why it matters

Hemotherapy depends on temperature-controlled blood components and cell therapy on cryopreserved cellular products, so the congress is the main Brazilian and Latin-American venue where blood-bank and cell-therapy cold-chain practice is discussed. Cold chain is intrinsic to the hemotherapy and cell-therapy tracks rather than a dedicated programme across the whole congress.

Who you'll meet

Hematologists, hemotherapy and transfusion-medicine specialists, blood-bank and cell-therapy staff, and biomedical scientists, drawn from Brazil and across Latin America, plus blood-establishment and cell-therapy equipment and cold-storage vendors. Attendance is clinical-scientific and Portuguese-speaking-centred.

Topics

Similar events

Who's going

Be the first to raise your hand.